866930-38-3Relevant articles and documents
GPR35 MODULATORS
-
Paragraph 00366, (2020/08/13)
Described herein are GPR35 modulators and methods of using these compounds in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
-
Page/Page column 42, (2008/06/13)
Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.